A share price of Guardant Health Inc [GH] is currently trading at $17.35, up 1.11%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GH shares have gain 7.97% over the last week, with a monthly amount drifted -3.40%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On December 13, 2023, Wolfe Research initiated with a Peer Perform rating. Raymond James upgraded its rating to a Outperform but stick to its price target of $27 on November 13, 2023. Bernstein initiated its recommendation with a Outperform and recommended $34 as its price target on September 28, 2023. Piper Sandler upgraded its rating to Overweight for this stock on September 27, 2023, but kept the price target unchanged to $40.
Guardant Health Inc experienced fluctuations in its stock price throughout the past year between $15.81 and $41.06. Currently, Wall Street analysts expect the stock to reach $68.86 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $17.35 at the most recent close of the market. An investor can expect a potential return of 296.89% based on the average GH price forecast.
Analyzing the GH fundamentals
Trailing Twelve Months sales for Guardant Health Inc [NASDAQ:GH] were 563.95M which represents 22.19% growth. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -1.0%, Pretax Profit Margin comes in at -0.85%, and Net Profit Margin reading is -0.85%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -3.02 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of7.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.91 points at the first support level, and at 16.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.66, and for the 2nd resistance point, it is at 17.96.
Guardant Health Inc [GH] reported earnings per share of -$1.58 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.86/share, meaning a difference of -$0.72 and a surprise factor of -83.70%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.73 per share as compared to estimates of -$0.94 per share, a difference of $0.21 representing a surprise of 22.30%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Guardant Health Inc [NASDAQ:GH] is 6.54. Also, the Quick Ratio is 6.24, while the Cash Ratio stands at 5.5. Considering the valuation of this stock, the price to sales ratio is 3.74, the price to book ratio is 13.30.
Transactions by insiders
Recent insider trading involved Kalia Kumud, Chief Information Officer, that happened on Mar 18 ’24 when 2187.0 shares were purchased. Director, Joyce Meghan V. completed a deal on Mar 04 ’24 to sell 100.0 shares. Meanwhile, Director Joyce Meghan V. sold 100.0 shares on Dec 04 ’23.
